ARTICLE | Company News

Sanofi turns infectious R&D over to Evotec

March 8, 2018 10:52 PM UTC

Sanofi (Euronext:SAN; NYSE:SNY) and Evotec AG (Xetra:EVT) partnered on Thursday to develop an infectious disease pipeline led by Evotec, seeded with more than 10 undisclosed early stage, preclinical assets from Sanofi's infectious disease portfolio excluding vaccines.

The companies said Evotec “will integrate” the pharma’s infectious disease research unit, which includes more than 100 employees, into its global drug discovery and development operations. ...

BCIQ Company Profiles

Evotec SE